We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Alliance to Develop Molecular Imaging Techniques

By HospiMedica staff writers
Posted on 17 Sep 2002
A collaboration to undertake development of molecular imaging techniques for use in ultrasound, magnetic resonance, and nuclear medicine has been announced by Philips Medical Systems (Best, The Netherlands) and Kereos (St.Louis, MO, USA).

The collaboration will focus on image-based characterization of the molecular causes of diseases and will combine Kereos' targeted nanoparticle technology with Philips' engineering, software development, and equipment support. The goal is to facilitate development of molecular imaging agents for specific and sensitive detection of tumors and vulnerable plaque in arteries, a major cause of heart disease. The leader of the project is Dr. Samuel A. Wickline, M.D., professor of medicine, biomedical engineering, and physics at Washington University School of Medicine in St. Louis (MO, USA).

"Our team is very excited about this agreement,” said Dr. Wickline. "We are certain that it will quickly lead to major breakthroughs in advancing contrast agent and scanner technology for molecular imaging and targeted therapeutics.”





Related Links:
Philips Medical Systems
Kereos
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Hemostatic Agent
HEMOBLAST Bellows

Channels

Surgical Techniques

view channel
Image: Assistant professor Yonghui Ding at left and an illustration of a 3D-printed blood vessel scaffold (Photo courtesy of WPI)

3D-Printed Blood Vessel Scaffolds Could Transform Heart Bypass Surgeries

A tiny, opaque tube held up in a lab may look unremarkable at first glance, but its microscopic surface features could mark a meaningful step forward in heart bypass surgery. Measuring just about one centimeter... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more